Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of the Effect of Narrowband Ultraviolet B Versus Methotrexate on Serum Chitotriosidase Level in Psoriasis.

NCT05427175 is registered in ClinicalTrials.gov with Aswan University Hospital as lead sponsor.

NCT NCT05427175
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05427175 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of the Effect of Narrowband Ultraviolet B Versus Methotrexate on Serum Chitotriosidase Level in Psoriasis.
Lead sponsor
Aswan University Hospital
Phase
Phase 4
Overall status
Unknown status
Start date
January 10, 2022
Completion date
September 15, 2023
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

psoriasis